11 Patents
- 0 cites
- US123701972025Combination Product of a Bcl-2/bcl-xl Inhibitor and a Chemotherapeutic Agent and Use Thereof in the Prevention And/or Treatment of Diseases
ASCENTAGE PHARMA GROUP Corp LIMITED
0 cites - US123433522025N-(phenylsulfonyl)benzamides and Related Compounds as Bcl-2 Inhibitors
ASCENTAGE PHARMA GROUP Corp LIMITED
0 cites - US122873382025Method and Compositions for Predicting Anti-cancer Efficacy of Compounds Targeting Apoptosis Pathway
Ascentage Pharma Group Corp Limited
0 cites - 0 cites
- 0 cites
- US121940242025Pharmaceutical Composition of MDM2 Inhibitor and Use Thereof for Preventing And/or Treating Disease
ASCENTAGE PHARMA GROUP Corp LIMITED
0 cites - US121863042025Method for Treating Cancer by Combination of IAP Inhibitor and Modulator of Immune Checkpoint Molecule
Ascentage Pharma (Suzhou) Co., Ltd.
0 cites - US120831362024Combination of BCL-2/BCL-XL Inhibitors and Chemotherapeutic Agent and Use Thereof
ASCENTAGE PHARMA (SUZHOU) CO., Ltd
0 cites - US118502392023MDM2 Inhibitor and a Platinum Compound for Cancer Treatment
Ascentage Pharma Group Corp Limited
0 cites - US115541272023Synergistic Antitumor Effect of Bcl-2 Inhibitor Combined with Rituximab And/or Bendamustine or Bcl-2 Inhibitor Combined with CHOP
ASCENTAGE PHARMA (SUZHOU) CO., Ltd.
0 cites